JUBLPHARMA

Jubilant Pharmova Share PriceJubilant Pharmova

₹432.6
14.8 (3.54%)
  • Advice
  • Hold
As on 28 November, 2023 | 22:23 BSE: 530019 NSE: JUBLPHARMAISIN: INE700A01033

Jubilant Pharmova Performance

Day Range

  • Low 409.4
  • High 436
432.6

52 Week Range

  • Low 268.9
  • High 485.1
432.6
  • Open Price419.85
  • Previous Close420.75
  • Volume417372

Start SIP in Jubilant Pharmova

Start SIP

Jubilant Pharmova Share Price

  • Over 1 Month 8.9%
  • Over 3 Month -7.35%
  • Over 6 Month 19.21%
  • Over 1 Year 13.34%

Jubilant Pharmova Key Statistics

P/E Ratio -154.5
PEG Ratio 1.2
Market Cap Cr 6,891
Price to Book Ratio 1.3
EPS 3.1
Dividend 1.2
Relative Strength Index 60.3
Money Flow Index 72.12
MACD Signal 3.88
Average True Range 16.98

Jubilant Pharmova Investment Rating

  • Master Rating:
  • Jubilant Pharmova has an operating revenue of Rs. 6,497.71 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 0% needs improvement, ROE of -1% is poor and needs improvement. The company has a debt to equity of 58%, which is bit higher. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 12% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 38 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 78 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Jubilant Pharmova Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 18620418918321520029
Operating Expenses Qtr Cr 18621319818521620930
Operating Profit Qtr Cr 142-27-4-2
Depreciation Qtr Cr 121111121192
Interest Qtr Cr 7666438
Tax Qtr Cr 1030-56-1-1
Net Profit Qtr Cr 02-31-692-5-3
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 948214
Operating Expenses Annual Cr 80795
Operating Profit Annual in Cr 3-7
Depreciation Cr 436
Interest Annual Cr 1931
Tax Annual Cr 294
Net Profit Annual Cr 5079
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -65-4
Cash from Investing Activity Annual Cr 3193
Cash from Financing Annual Activity Cr 23-107
Net Cash Flow Annual Cr -12-18
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 2,4151,282
Fixed Assets Annual Cr 734124
Total Non Current Assets Annual Cr 2,4301,782
Total Current Assets Annual Cr 57948
Total Assets Annual Cr 3,0081,829
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 15280
ROE Annual % 26
ROCE Annual % 46
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 17136
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1,6671,5671,6611,5531,5851,4401,514
Operating Expenses Qtr Cr 1,4391,4171,4591,4071,3811,2591,280
Operating Profit Qtr Cr 242170219146219192234
Depreciation Qtr Cr 9790271949495101
Interest Qtr Cr 66625651424040
Tax Qtr Cr 36191425312247
Net Profit Qtr Cr 636-98-1654760
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 6,3206,141
Operating Expenses Annual Cr 5,5054,974
Operating Profit Annual in Cr 7761,156
Depreciation Cr 554382
Interest Annual Cr 188145
Tax Annual Cr 93217
Net Profit Annual Cr -61414
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 661838
Cash from Investing Activity Annual Cr -544-380
Cash from Financing Annual Activity Cr -157-33
Net Cash Flow Annual Cr -40425
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 5,3995,319
Fixed Assets Annual Cr 4,3163,717
Total Non Current Assets Annual Cr 7,3946,482
Total Current Assets Annual Cr 3,7623,509
Total Assets Annual Cr 11,1579,991
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 339334
ROE Annual % -18
ROCE Annual % 39
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1319

Jubilant Pharmova Technicals

EMA & SMA

Current Price
₹432.6
14.8 (3.54%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹414.85
  • 50 Day
  • ₹412.37
  • 100 Day
  • ₹405.83
  • 200 Day
  • ₹393.74
  • 20 Day
  • ₹409.68
  • 50 Day
  • ₹412.02
  • 100 Day
  • ₹414.53
  • 200 Day
  • ₹371.85

Jubilant Pharmova Resistance and Support

PIVOT
₹426.
Resistance
First Resistance ₹442.6
Second Resistance ₹452.6
Third Resistance ₹469.2
RSI 60.3
MFI 72.12
MACD Single Line 3.88
MACD 6.42
Support
First Resistance ₹416
Second Resistance ₹399.4
Third Resistance ₹389.4

Jubilant Pharmova Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 462,621 24,662,326 53.31
Week 275,295 16,649,811 60.48
1 Month 451,144 21,388,751 47.41
6 Month 354,802 13,237,665 37.31

Jubilant Pharmova Result Highlights

Jubilant Pharmova Synopsis

NSE-Medical-Diversified

Jubilant Pharmova is involved in the business activities of Manufacture of basic chemicals. Company’s Total Operating Revenue is Rs. 810.12 Cr. and Equity Capital is Rs. 15.93 Cr. for the Year ended 31/03/2023. Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624.
Market Cap 6,839
Sales 786
Shares in Float 7.80
No of funds 152
Yield 1.2
Book Value 2.76
U/D Vol ratio 1.5
LTDebt / Equity 7
Alpha 0.02
Beta 1.29

Jubilant Pharmova

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 50.68%50.68%50.68%50.68%
Mutual Funds 0.42%0.41%0.4%0.4%
Foreign Portfolio Investors 23.2%23.2%23.22%23.38%
Financial Institutions/ Banks
Individual Investors 18.24%18.25%18.69%18.68%
Others 7.46%7.46%7.01%6.86%

Jubilant Pharmova Management

Name Designation
Mr. Shyam S Bhartia Chairman
Mr. Hari S Bhartia Co-Chairman
Mr. Priyavrat Bhartia Managing Director
Mr. Arjun Shanker Bhartia Joint Managing Director
Mr. Arvind Chokhany WholeTime Director & Group CFO
Mr. R Kumar Whole Time Director
Mr. Vivek Mehra Independent Director
Mr. Sushil Kumar Roongta Independent Director
Mr. Arun Seth Independent Director
Ms. Sudha Pillai Independent Director
Dr. Ashok Misra Independent Director
Mr. S Sridhar Independent Director
Mr. Shirish G Belapure Independent Director

Jubilant Pharmova Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jubilant Pharmova Corporate Action

Date Purpose Remarks
2023-10-27 Quarterly Results
2023-07-19 Quarterly Results
2023-05-29 Audited Results & Final Dividend
2023-02-03 Quarterly Results
2022-10-21 Quarterly Results
Date Purpose Remarks
2023-08-10 FINAL Rs.5.00 per share(500%)Final Dividend
2022-08-12 FINAL Rs.5.00 per share(500%)Final Dividend
2021-08-06 FINAL Rs.5.00 per share(500%)Final Dividend

Jubilant Pharmova MF Shareholding

Name Amount(cr)
Nippon India Pharma Fund - Growth 5539
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 719
Motilal Oswal Nifty 500 Fund Regular Growth 548
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 453
SBI Nifty Smallcap 250 Index Fund Regular Growth 332

Jubilant Pharmova FAQs

What is Share Price of Jubilant Pharmova ?

Jubilant Pharmova share price is ₹432 As on 28 November, 2023 | 22:09

What is the Market Cap of Jubilant Pharmova ?

The Market Cap of Jubilant Pharmova is ₹6890.5 Cr As on 28 November, 2023 | 22:09

What is the P/E ratio of Jubilant Pharmova ?

The P/E ratio of Jubilant Pharmova is -154.5 As on 28 November, 2023 | 22:09

What is the PB ratio of Jubilant Pharmova ?

The PB ratio of Jubilant Pharmova is 1.3 As on 28 November, 2023 | 22:09

Q2FY23